These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5297525)

  • 1. The effect of fibrin proteolysis inhibitors on the level of fibrinogen and the activity of antithrombin VI in citrated stored blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1966; 4(4):455-60. PubMed ID: 5297525
    [No Abstract]   [Full Text] [Related]  

  • 2. Separation and estimation split "products" of fibrinogen and fibrin in human serum.
    Niléhn JE
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):487-98. PubMed ID: 4952978
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC; Muirhead CR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):397-402. PubMed ID: 5304346
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental investigations with proteinase inhibitors.
    Nordström S; Blombäck M; Olsson P; Zetterqvist E
    Acta Chir Scand Suppl; 1967; 378():33-40. PubMed ID: 5300105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of tsalol and epsilon-aminocaproic acid in preserving blood].
    Katsadze IuL; Shulutko LS
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):52-3. PubMed ID: 4543610
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of addition of episilon-aminocaproic acid on the proteolytic activity and concentration of some coagulation proteins of the citrated stored blood.
    Janda R; Maciejewicz J
    Folia Histochem Cytochem (Krakow); 1966; 4(4):439-46. PubMed ID: 5959690
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Trasylol on fibrinogen and on fibrinogen-like substances after major surgery.
    Godal HC; Skaga E
    Acta Chir Scand Suppl; 1967; 378():41-4. PubMed ID: 5299855
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
    Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
    Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitors of proteolysis and serum hemoglobin after transfusion of incompatible blood in rabbits].
    Laurentaci G; Sorace R; Carpagnano F
    Osp Ital Chir; 1968 Jan; 18(1):19-24. PubMed ID: 5309744
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of epsilon aminocaproic acid (EACA) and Trasylol on thromboplastin-induced intravascular coagulation, studied in dogs with iodine-labelled fibrinogen.
    Nordstrm S; Zetterqvist E
    Acta Physiol Scand; 1969; 76(1):93-105. PubMed ID: 5307271
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels.
    Huang CY; Deitzer MA; Cheung HS
    Biomech Model Mechanobiol; 2007 Jan; 6(1-2):5-11. PubMed ID: 16691415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 15. The measurement of fibrinogen and its derivatives. 3. Thrombin clottable fibrinogen estimates in the presence of epsilon amino caproic acid, fibrinogen and fibrin degradation products.
    Farrell GW; Wolf P
    Med Lab Technol; 1971 Jul; 28(3):328-36. PubMed ID: 5314853
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental data on the existence and significance of an anticoagulating system in fish].
    Kudriashov BA; Kalishevskaia TM; Bazaz'ian GG; Volkov VN
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 2():31-6. PubMed ID: 4824513
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of trasylol added to citrated stored blood on its proteolytic activity and concentration of some coagulation proteins.
    Janda R; Maciejewicz J
    Folia Histochem Cytochem (Krakow); 1966; 4(4):447-53. PubMed ID: 5297524
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the transplantation barrier in the light of proteolysis inhibitors.
    Gieldanowski J; Patkowski J; Halawa B
    Arch Immunol Ther Exp (Warsz); 1969; 17(4):501-6. PubMed ID: 4896891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental fibrinogenopathy after reaction of human fibrinogen with beta propiolactone: antithrombin activity, effect on platelet aggregation and function and on fibrin stabilization phase].
    Brunner H; Wenzel E; Holzhüter H; Oppolzer R
    Verh Dtsch Ges Inn Med; 1973; 79():1330-4. PubMed ID: 4790174
    [No Abstract]   [Full Text] [Related]  

  • 20. Preservation of vascular patency as a function of reticuloendothelial clearance.
    Gans H
    Surgery; 1966 Dec; 60(6):1216-23. PubMed ID: 5951295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.